Harvard Bioscience (HBIO) Prepaid Assets (2010 - 2026)

Harvard Bioscience (HBIO) has 17 years of Prepaid Assets data on file, last reported at $3.6 million in Q1 2026.

• Prepaid Assets for Q1 2026 came in at $3.6 million, up 17.74% year-over-year; the trailing twelve-month figure through Mar 2026 was $3.6 million (up 17.74% YoY), and the FY2025 annual result was $2.8 million, down 4.66% from the prior year.
• Prepaid Assets grew to $3.6 million in Q1 2026 per HBIO's latest filing, from $2.8 million in the prior quarter.
• Over five years, Prepaid Assets peaked at $5.5 million in Q3 2022 and troughed at $2.8 million in Q4 2025.
• A 5-year average of $4.0 million and a median of $3.9 million in 2023 frame the typical range for Prepaid Assets.
• The sharpest annual moves came in 2022 and 2025: Prepaid Assets surged 37.51% in 2022, then plunged 31.18% in 2025.
• A 5-year view of Prepaid Assets shows it stood at $3.5 million in 2022, then climbed by 13.48% to $3.9 million in 2023, then slipped by 26.45% to $2.9 million in 2024, then dropped by 4.66% to $2.8 million in 2025, then jumped by 30.44% to $3.6 million in 2026.
• Business Quant data shows HBIO's Prepaid Assets at $3.6 million in Q1 2026, $2.8 million in Q4 2025, and $3.3 million in Q3 2025.